MARKET

UBX

UBX

Unity Btech
NASDAQ
1.040
-0.100
-8.77%
After Hours: 1.040 0 0.00% 19:47 03/31 EDT
OPEN
1.200
PREV CLOSE
1.140
HIGH
1.220
LOW
1.011
VOLUME
254.17K
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
0.9397
MARKET CAP
17.54M
P/E (TTM)
-0.6734
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at UBX last week (0324-0328)?
Weekly Report · 16h ago
Unity Biotechnology price target lowered to $4 from $8 at H.C. Wainwright
TipRanks · 6d ago
Unity Biotechnology price target lowered to $4 from $6 at Chardan
TipRanks · 6d ago
Unity Biotechnology Is Maintained at Buy by Chardan Capital
Dow Jones · 6d ago
Unity Biotechnology Price Target Cut to $4.00/Share From $6.00 by Chardan Capital
Dow Jones · 6d ago
Unity Biotechnology Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 6d ago
Unity Biotechnology Price Target Cut to $4.00/Share From $8.00 by HC Wainwright & Co.
Dow Jones · 6d ago
Chardan Capital Maintains Buy on Unity Biotechnology, Lowers Price Target to $4
Benzinga · 6d ago
More
About UBX
More
UNITY Biotechnology, Inc. is a biotechnology company engaged in researching and developing therapeutics to slow, halt or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. It is targeting specific biological mechanisms implicated in diseases of aging. Its core therapeutic approach targets cellular senescence, and it is advancing senolytic programs primarily in ophthalmologic disorders. It has other programs based on other biologies of aging to include an agonistic antibody to the Tie2 receptor and a Tie2/VEGF bispecific to treat vascular eye disease. UBX1325 is its advanced drug candidate for age-related diseases of the eye, including diabetic macular edema. UBX1325 is a potent small molecule inhibitor of BCL-xL. UBX2089, an α-Klotho hormone drug candidate, is being researched for multiple neurology indications.
Recently
Symbol
Price
%Change

Webull offers Unity Biotechnology Inc stock information, including NASDAQ: UBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UBX stock methods without spending real money on the virtual paper trading platform.